Abstract Formation and accumulation of fibrillar plaques and aggregates of B-amyloid peptide (AB) in bmin have been recognized as chamcteristics of Alzheimer's disease (AD). Oligomeric aggregates of AB are considered critical intermediates leading to progressive neurodegeneration;· however, molecular details of the oligomerization and aggregation pathway and the structures of AB-oligomers are hitherto unclear. Using an in vitro fibril formation procedure of AB(I-40), B-amyloid aggregates were prepared and insoluble aggregates separated from soluble products by centrifugation. In this study, ion mobility mass spectrometry (lM-MS) was applied in combination with electron pammagnetic resonance spectroscopy (EPR) to the identification of the components of AB-oligomers, and to their structuml and topographical chamcterization. The formation of AB-oligomers and aggregates was monitored by . gel electrophoresis, and AB-oligomer bands were identified by in-gel tryptic digestion and matrix-assisted . laser desorption ionization-mass spectrometry (MALDI-MS) to consist predominantly of AB(I-40) peptide. First, ion mobility-MS studies of soluble AB-aggregates prepared by incubation for 5 days were performed on a quadrupole timeof-flight mass spectrometer and revealed (1) the presence of at least two different confonnational states, and (2), the formation ofMet-35 oxidized products. For estimation of the size of AB-aggregates using EPR spectroscopy, a modified peptide containing an additional N-terminal cysteine residue was prepared, and a 3-(2-iodoacetamido)-2,2,5,5-tetramethyl-I-pyrrolidinyloxy radical spin label derivative (IPSL) was coupled by S-alkylation. The EPR spectm of the spin-labeled Cys-AB(I-40) oligomers were matched with spectra simulations using a mUlti-component simulation strategy, resulting in complete agreement with the gel electrophoresis results.
B-amyloid peptide (AB) and (X-synuclein (Syn) in brain have been recognized as characteristics of Alzheimer's disease (AD) and Parkinson's disease (PD) [1 '-3] . AB is a polypeptide containing 39-43 amino acid residues derived from proteolytic cleavage of the transmembrane AB precursor protein" (APP). Recently, the formation of AB-oligomers has become of particular interest, since oligomers have been suggested to be key neurotoxic species for progressive neurodegeneration [2, 4, 5] ; however, molecular details of the pathophysiological degradation of APP, and of AB-aggregation pathways are hitherto unclear [6] . Despite the lack of molecular mechanism(s), studies towards the development of immunotherapeutic approaches for AD [7] have shown initial success in the production of therapeutic antibodies that disaggregate AB-fibrils and improve the memory impairment in transgenic AD mice [8] [9] [10] [11] . The identification of the epitopes recognized by both AB-plaque specific and aggregation-preventing antibodies, and the discovery of their AB-oligomer specificity are presently causing enhanced interest in the elucidation of AB-oligomeric structures [12] [13] [14] [15] [16] .
Ion mobility mass spectrometry (IM-MS) is a new MS method that has received increasing attention as a tool for the characterization of molecular assemblies according to their conformation and/or topography [17] [18] [19] [20] . The IM-MS instrument employed in this study consists of two parts, (a) an ion mobility drift cell where ions are separated within an electric field according to their collisional cross-section, and (b) a quadrupole time-of-flight mass" spectrometer (Synapt-QTOF-MS) [21] [22] [23] . Thus, the IM-MS implements a new mode of separation that allows the differentiation of protein conformational states.
EPR spectroscopy is a technique for studying chemical species with unpaired electrons that has recently shown to be an efficient bioanalytical tool for determination of molecular distances and molecular size estimations from spin motion measurements [24] [25] [26] [27] [28] [29] [30] . This technique has recently shown high sensitivity compared to the traditional techniques for protein structure determination, such as NMR spectroscopy [31] . In this study, ion mobility-MS in combination with EPR was applied to the study of AB-oligomers prepared in vitro from AB(l--40). For EPR studies of AB-oligomers and aggregates, N-cysteinyl-AB(I--40) peptides were synthesized by solid phase peptide synthesis (SPPS) and an 3-(2-iodoacetamido )-2,2,5,5-tetramethyl-I-pyrrolidinyloxy (iodo-proxyl) spin label derivative (IPSL) was attached to the N-terminal cysteine residue by alkylation. The complementary application of IM-MS and EPR provided first molecular details of AB-oligomers by the identification of oxidative structure modifications, and an estimation of the size and shape of AB-oligomers. each full MS scan with a maximum accumulation time of 200 ms for each ion.
Preparation of AB-fibrils
For AB-oligomerization and fibril formation, AB(I-40) and PSL-Cys-AB(l-40) peptides were solubilized at a concentration of 1 Ilg/IlL in a buffer containing 50 mM Na3P04, 150 mM NaCl, 0.02% NaN 3 at pH 7.5 [30] . Because of the low solubility of AB-fibrils, several sonication/vortex cycles were performed to ensure complete solubilization. Each solution was incubated for 5 days at 37°C, yielding a white precipitate at the end of the incubation period. The precipitate was briefly sonicated, centrifuged 15 min at 13,000 rpm, and the supernatant removed and replaced with an equal volume of deionized water (MilliQ). Both the supernatant and the resuspended precipitate were subjected to gel electrophoresis and EPR spectroscopy experiments.
Gel electrophoresis
For in-gel proteolytic digestion and mass spectrometry, the resuspended precipitate fraction was subjected to SDS-PAGE separation. The fibril fraction (10 ilL) was mixed with 10 ilL sample buffer, 4% SDS, 25% glycerol, and bromophenol blue staining reagent. After loading on a 15% gel, electrophoresis was developed for 15 min at 60 V, and subsequently for 1-2 h at 100 V. Gel electrophoresis of the spin-labeled IPSL-Cys-AB( 1-40) fibril preparation was carried out with a freshly prepared solution in fibril growth buffer, and a sample after incubation for 5 days (supernatant and resuspended precipitate). ID Tris-tricine polyacrylamide gel electrophoresis (15%) was run as described above and visualized by Coomassie blue staining.
In-gel tryptic digestion and peptide extraction Protein spots were cut from the gel (Fig. 2a, The gel pieces were then swollen in digestion buffer (12.5 ng trypsin/,.t! 50 m~ NH 4 HC0 3 ) at 4°C (on ice) for 45 min, and incubated at 37°C overnight (12 h). After removal of supernatant, peptide extraction was perfonned at 25°C with a solution of 60% acetonitrile, 0.1 % TFA in MiIIiQ water (three steps of 1 h each). The tryptic digestion mixtures were analyzed by MALDI-TOF MS, and data were searched against the. NCBInr protein database by means of the Mascot MS MS ion search engine.
Ion mobility mass spectrometry Ion mobility mass spectrometry was performed with a Waters SYNAPT quadrupole time-of-flight (QTOF) mass Electron paramagnetic resonance spectroscopy
The freshly prepared IPSL-Cys-AB(I-40) solution (in fibril growth buffer), and a sample incubated for 5 days as described above (precipitate and supematant) were used for EPR spectroscopy. EPR spectra were obtained on a MiniScope MS200 (Magnettech GmbH, Berlin, Germany) spectrometer at 25°C. An accumulation of 60 scans was carried out at I minlscan; the modulation amplitude was set at 400 G and the attenuation at 23 dB. Following acquisition, the spectra were fitted by simulations using the EasySpin package [33] and Matlab (The Math Works Inc., Natick, Massachusetts, United States) software. From these simulations, multiple fractions featuring significantly 
Results and discussion

Synthesis and characterization of spin-labeled A/3-peptides
AB(I-40) and N-cysteinyl-AB(I-40)
peptides were synthesized by SPPS at the 100 f.tM scale according to the Fmoc strategy, and the crude products purified by RP-HPLC (Fig. I) . AB(1-40) was separated at a retention time of 21.3 min at the HPLC conditions employed, while the Cys-AB(1-40) derivative was isolated with 'a slightly different retention time of 20.5 min (Fig. la) . For the preparation of the IPSL-spin-labeled peptide derivative (see Fig. Ib directly for alkylation with IPSL, in order to minimize oxidation and disulfide bridge formation at the N-tenninal cysteine residue. To prevent disulfide formation, the IPSL derivative was used at a tenfold molar excess compared to the AB-peptide; at these conditions no dimeric AB-peptide derivatives were observed. The HPLC profile showed the presence of two peaks at 13.6 and 21.5 min, respectively ( Fig. 1 b) ; however, MALDI-MS analyses confirmed the presence of only one AB-peptide at 21.5 min due to the IPSL-Cys-AB(I-40), while the compound at a retention time of 13.6 min was found to be unreacted spin-label reagent.
The HPLC-purified peptides, AB( 1-40), Cys-AB( 1-40), and IPSL-Cys-AB(1-40) were also subjected to LC-MS analysis (Fig. 2) which confirmed the expected molecular masses. In all cases, the multiply charged molecular ions (6+ and 7+) were found to be the most abundant ions, with loss of one water molecule as the only detectable fragmentation.
Gel electrophoresis and mass spectrometric characterization of in vitro AB-oligomer fonnation
Due to the insolubility of AB-aggregates, fibril fonnation cannot be studied directly by mass spectrometry. In order to determine the molecular composition of aggregates, in-gel tryptic digestion and mass spectrometric analysis of the AB-oligomeric gel bands was performed. AB(l-40) was solubilized at I )..lg/)..lL (220 )..lM) in fibril growth buffer solution, pH 7.5 and incubated for 5 days at 37°C. At the end of the incubation, fibrils were obtained as a white precipitate, sonicated, and centrifuged for 15 min, as described in the "Materials and methods" section, and the supematant was separated from the precipitate for ion mobility-MS. The precipitate was separated from the supematant, resuspended in MiIIiQ water, and subjected to polyacrylamide gel electrophoresis (Fig. 3) . Only the fraction soluble in running buffer entered the gel (Fig. 3a) while the insoluble part remained at the top of the stacking gel (data not shown). This soluble fraction was found by MALDI-MS to contain monomeric AB (Fig. 3a, band 1) , AB-oligomers at approximately 20 kDa (pentamer, Fig. 3a-band 2) , and high-molecular-weight aggregates at > 100 kDa (Fig. 3a, bands 3 and 4) . The AB-oligomers in Fig. 3a were not separated by SDS-PAGE, but provided separation into defined AB-oligomers (dimers to pentamers) in Tris-tricine PAGE (data not shown). All gel bands were cut out, digested with Trypsin and analyzed by MALDI-MS. The mass spectrometric data ascertained the presence of AB-peptides in all gel bands by the corresponding peptide fragments (Table I and Fig. 4) .
The preparation of aggregates of the spin-Iabeled IPSLCys-AB(I-40) peptide was carried out at identical con-ditions, by incubation of a 200 )..lM solution for 5 days at 37°C. Following incubation, supematant and precipitate were separated by centrifugation and the precipitate suspended in MilliQ water for gel electrophoresis. Tristricine PAGE analysis was performed with a freshly prepared IPSL-Cys-AB( 1-40) solution in fibril growth buffer, the supematant and the fibril suspension of the spin-Iabeled AB-aggregates (Fig. 3b) . The gel showed that the IPSL-Cys-AB(I-40) peptide started to aggregate already during the solubilization, as indicated by dimeric and trimeric gel bands (Fig. 3b, lane 1) . From the fibril precipitate, only the fraction soluble in running buffer entered the separation gel (Fig. 3b) , the insoluble part remaining at the top of the stacking gel (data not shown). In the gel, the presence of monomer, dimer, and trimer, and some high-molecular-weight aggregates with a molecular (gray) and corresponding simulations (black; see Table 2 and "Materials and methods" section for parameters) 2517 weight beyond 200 kDa were observed (Fig. 3b, lane 2) . In contrast, the supernatant showed only the b'and of the AB monomer (Fig. 3b, lane 3) .
Characterization of AB-oligomers by ion mobility mass spectrometry
The soluble fraction of the AB(I-40) fibril preparation, obtained by AB-incubation for S days at 37°C, and a freshly prepared AB( 1-40) peptide solution (220 f!M) were subjected to comparative analysis by ion mobility-MS ( Fig. Sa and b) . In the freshly prepared AB ( Fig. 6a, b together with the drift scope of the S+, 6+, and 7+ ions. The deconvoluted spectrum of the fibril preparation is shown in Fig. 6c . From the mass spectrometric data of the ion mobility profiles, modifications of AB by oxidation and loss of one water molecule could be identified, in addition to the intact AB(1-40) monomer. The oxidation at the Met 35 residue of AB was confirmed by MS/MS sequence determination (data not shown).
Characterization of spin-labeled AB-aggregates by electron paramagnetic resonance spectroscopy First EPR spectroscopic determinations of the spin-labeled AB monomer peptide, in comparison with the AB-fibril preparations, were performed with the aim to obtain infonnation about the size of AB-aggregates monitored by the local spin-label mobilities. EPR spectra of the freshly Table 2 Fractions contributing to the EPR spectra as derived from simulation parameters (cf. -40) , the precipitate residue and the soluble AB-fibril preparation are compared in Fig. 7a-c) . All spectra were quantitatively analyzed by spectral-Iineshape-simulations. The supematant spectrum (Fig. 7c) could be described by a single component, the other spectra consist of at least two additional components which were significantly broadened relative to the supernatant spectrum. This broadening reflects the reduced mobility of the spin-label-side group due to oligomerization arid/or aggregation.
Using a multi-component simulating strategy a number of spectral components was chosen in accordance with the gel electrophoretic results in order to simulate the spectra. The fractions of the contributing components as well as their rotational correlation times could be identified ( Table 2 ). The supematant of the fibril preparation sample was found to contain only one component which could be attributed to the AB-monomer, again in agreeinent with the gel electrophoresis data (Fig. 3b, lane 3) . In the freshly prepared IPSL-Cys-AB( 1--40) solution, the corresponding, AB-mono mer component was found only with a relative amount of approximately 19%. In addition, two further contributions presumably representing oligomers were found. In the fibril precipitate, the identical mixture of components was found, but the main component (76%) featured a very slow rotational correlation time suggesting that this component can be attributed to fibrils. Thus, the EPR data were in complete agreement with the gel electrophoretic separation of AB-aggregates, suggesting that aggregation starts rapidly upon solubilization of monomeric AB-peptide in the fibril growth buffer. In the precipitate, almost exclusively high-molecular-weight compounds were found.
Conclusions
In the present study, ion mobility-MS in combination with electron paramagnetic resonance spectroscopy was explored for the characterization of the oligomerization and fibril formation reaction of B-amyloid in vitro. The results obtained here indicate the combination of both methods as an efficient tool to characterize the composition of oligomerization products, and the molecular dimensions of aggregate products. The EPR spectra and gel electrophoresis data were in complete agreement to show that (a) AB-aggregation in vitro begins rapidly upon solubilization of the AB-monomer, and (b) the insoluble fibril product contains large aggregates; while in the supematant, the soluble AB-monomer is predominant. The ion mobility-MS data provide evidence of (a) the presence of at least two different confonnational fonns involved in AB-aggregation, and (b) the formation of a Met'S oxidized AB peptide M.l. lura~cu et al.
during the oligomerization and aggregation. Hence, the complementarity of both methods appears promising for the characterization of the AB-oligomerization and aggregation pathway. Corresponding studies us;ing suitably modified AB-peptides is presently carried out in our laboratory.
